ICH Q10 – Pharmaceutical Quality Systems – ‘An Opportunity for Us All’
If you have not yet reviewed the content of the ICH Q10 guideline and considered its impact on your company’s quality system operations, then it makes good business sense for you to do so.
This white paper will attempt to convince you, the reader, that this common argument is not valid and that something new is necessary (i.e., ICH Q10) to improve the performance of the pharmaceutical industry and to facilitate more science and risk-based regulatory approaches.
